Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: .

1		2007	2006	2005

2	weighted average exercise price per share	$ 60.94	$ 37.84	$ 25.14

3	expected annual dividends per share	$ 0.96	$ 0.80	$ 0.66

4	expected life in years	5.0	5.1	5.5

5	expected volatility	27% ( 27 % )	28% ( 28 % )	28% ( 28 % )

6	risk-free interest rate	4.1% ( 4.1 % )	5.0% ( 5.0 % )	3.8% ( 3.8 % )

7	weighted average grant date fair value of stock option awards granted	$ 17.24	$ 10.19	$ 6.15

 .
Conversations:
Question: how much did the weighted average exercise price per share increase between 2005 and 2007?
Answer:

Answer: 35.8


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: .

1		2007	2006	2005

2	weighted average exercise price per share	$ 60.94	$ 37.84	$ 25.14

3	expected annual dividends per share	$ 0.96	$ 0.80	$ 0.66

4	expected life in years	5.0	5.1	5.5

5	expected volatility	27% ( 27 % )	28% ( 28 % )	28% ( 28 % )

6	risk-free interest rate	4.1% ( 4.1 % )	5.0% ( 5.0 % )	3.8% ( 3.8 % )

7	weighted average grant date fair value of stock option awards granted	$ 17.24	$ 10.19	$ 6.15

 .
Conversations:
q0: how much did the weighted average exercise price per share increase between 2005 and 2007? {answer0}
Question: so what was the percentage change during this time?
Answer:

Answer: 1.42403


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: .

1		2007	2006	2005

2	weighted average exercise price per share	$ 60.94	$ 37.84	$ 25.14

3	expected annual dividends per share	$ 0.96	$ 0.80	$ 0.66

4	expected life in years	5.0	5.1	5.5

5	expected volatility	27% ( 27 % )	28% ( 28 % )	28% ( 28 % )

6	risk-free interest rate	4.1% ( 4.1 % )	5.0% ( 5.0 % )	3.8% ( 3.8 % )

7	weighted average grant date fair value of stock option awards granted	$ 17.24	$ 10.19	$ 6.15

 .
Conversations:
q0: how much did the weighted average exercise price per share increase between 2005 and 2007? {answer0}
q1: so what was the percentage change during this time? {answer1}
Question: what were the total tax benefits for deductions in 2007 and 2006 in excess of the stock-based compensation expense for options exercised and other stock-based awards vested?
Answer:

Answer: 66.0


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: masco corporation notes to consolidated financial statements ( continued ) h . goodwill and other intangible assets ( continued ) goodwill at december 31 , accumulated impairment losses goodwill at december 31 , 2010 additions ( a ) discontinued operations ( b ) pre-tax impairment charge other ( c ) goodwill at december 31 , cabinets and related products . . . . . . . . . . . $ 587 $ ( 364 ) $ 223 $ 2014 $ 2014 $ ( 44 ) $ 2 $ 181 .

1		gross goodwill at december 31 2010	accumulated impairment losses	net goodwill at december 31 2010	additions ( a )	discontinued operations ( b )	pre-tax impairment charge	other ( c )	net goodwill at december 31 2011

2	cabinets and related products	$ 587	$ -364 ( 364 )	$ 223	$ 2014	$ 2014	$ -44 ( 44 )	$ 2	$ 181

3	plumbing products	536	-340 ( 340 )	196	9	2014	2014	-4 ( 4 )	201

4	installation and other services	1819	-762 ( 762 )	1057	2014	-13 ( 13 )	2014	2014	1044

5	decorative architectural products	294	2014	294	2014	2014	-75 ( 75 )	2014	219

6	other specialty products	980	-367 ( 367 )	613	2014	2014	-367 ( 367 )	2014	246

7	total	$ 4216	$ -1833 ( 1833 )	$ 2383	$ 9	$ -13 ( 13 )	$ -486 ( 486 )	$ -2 ( 2 )	$ 1891

 ( a ) additions include acquisitions . ( b ) during 2011 , the company reclassified the goodwill related to the business units held for sale . subsequent to the reclassification , the company recognized a charge for those business units expected to be divested at a loss ; the charge included a write-down of goodwill of $ 13 million . ( c ) other principally includes the effect of foreign currency translation and purchase price adjustments related to prior-year acquisitions . in the fourth quarters of 2012 and 2011 , the company completed its annual impairment testing of goodwill and other indefinite-lived intangible assets . the impairment test in 2012 indicated there was no impairment of goodwill for any of the company 2019s reporting units . the impairment test in 2011 indicated that goodwill recorded for certain of the company 2019s reporting units was impaired . the company recognized the non-cash , pre-tax impairment charges , in continuing operations , for goodwill of $ 486 million ( $ 330 million , after tax ) for 2011 . in 2011 , the pre-tax impairment charge in the cabinets and related products segment relates to the european ready-to- assemble cabinet manufacturer and reflects the declining demand for certain products , as well as decreased operating margins . the pre-tax impairment charge in the decorative architectural products segment relates to the builders 2019 hardware business and reflects increasing competitive conditions for that business . the pre-tax impairment charge in the other specialty products segment relates to the north american window and door business and reflects the continuing weak level of new home construction activity in the western u.s. , the reduced levels of repair and remodel activity and the expectation that recovery in these segments will be modestly slower than anticipated . the company then assessed the long-lived assets associated with these business units and determined no impairment was necessary at december 31 , 2011 . other indefinite-lived intangible assets were $ 132 million and $ 174 million at december 31 , 2012 and 2011 , respectively , and principally included registered trademarks . in 2012 and 2011 , the impairment test indicated that the registered trademark for a north american business unit in the other specialty products segment and the registered trademark for a north american business unit in the plumbing products segment ( 2011 only ) were impaired due to changes in the long-term outlook for the business units . the company recognized non-cash , pre-tax impairment charges for other indefinite- lived intangible assets of $ 42 million ( $ 27 million , after tax ) and $ 8 million ( $ 5 million , after tax ) in 2012 and 2011 , respectively . in 2010 , the company recognized non-cash , pre-tax impairment charges for other indefinite-lived intangible assets of $ 10 million ( $ 6 million after tax ) related to the installation and other services segment ( $ 9 million pre-tax ) and the plumbing products segment ( $ 1 million pre-tax ) . .
Conversations:
Question: what was the net change in value of total net goodwill from 2010 to 2011?
Answer:

Answer: -492.0


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: masco corporation notes to consolidated financial statements ( continued ) h . goodwill and other intangible assets ( continued ) goodwill at december 31 , accumulated impairment losses goodwill at december 31 , 2010 additions ( a ) discontinued operations ( b ) pre-tax impairment charge other ( c ) goodwill at december 31 , cabinets and related products . . . . . . . . . . . $ 587 $ ( 364 ) $ 223 $ 2014 $ 2014 $ ( 44 ) $ 2 $ 181 .

1		gross goodwill at december 31 2010	accumulated impairment losses	net goodwill at december 31 2010	additions ( a )	discontinued operations ( b )	pre-tax impairment charge	other ( c )	net goodwill at december 31 2011

2	cabinets and related products	$ 587	$ -364 ( 364 )	$ 223	$ 2014	$ 2014	$ -44 ( 44 )	$ 2	$ 181

3	plumbing products	536	-340 ( 340 )	196	9	2014	2014	-4 ( 4 )	201

4	installation and other services	1819	-762 ( 762 )	1057	2014	-13 ( 13 )	2014	2014	1044

5	decorative architectural products	294	2014	294	2014	2014	-75 ( 75 )	2014	219

6	other specialty products	980	-367 ( 367 )	613	2014	2014	-367 ( 367 )	2014	246

7	total	$ 4216	$ -1833 ( 1833 )	$ 2383	$ 9	$ -13 ( 13 )	$ -486 ( 486 )	$ -2 ( 2 )	$ 1891

 ( a ) additions include acquisitions . ( b ) during 2011 , the company reclassified the goodwill related to the business units held for sale . subsequent to the reclassification , the company recognized a charge for those business units expected to be divested at a loss ; the charge included a write-down of goodwill of $ 13 million . ( c ) other principally includes the effect of foreign currency translation and purchase price adjustments related to prior-year acquisitions . in the fourth quarters of 2012 and 2011 , the company completed its annual impairment testing of goodwill and other indefinite-lived intangible assets . the impairment test in 2012 indicated there was no impairment of goodwill for any of the company 2019s reporting units . the impairment test in 2011 indicated that goodwill recorded for certain of the company 2019s reporting units was impaired . the company recognized the non-cash , pre-tax impairment charges , in continuing operations , for goodwill of $ 486 million ( $ 330 million , after tax ) for 2011 . in 2011 , the pre-tax impairment charge in the cabinets and related products segment relates to the european ready-to- assemble cabinet manufacturer and reflects the declining demand for certain products , as well as decreased operating margins . the pre-tax impairment charge in the decorative architectural products segment relates to the builders 2019 hardware business and reflects increasing competitive conditions for that business . the pre-tax impairment charge in the other specialty products segment relates to the north american window and door business and reflects the continuing weak level of new home construction activity in the western u.s. , the reduced levels of repair and remodel activity and the expectation that recovery in these segments will be modestly slower than anticipated . the company then assessed the long-lived assets associated with these business units and determined no impairment was necessary at december 31 , 2011 . other indefinite-lived intangible assets were $ 132 million and $ 174 million at december 31 , 2012 and 2011 , respectively , and principally included registered trademarks . in 2012 and 2011 , the impairment test indicated that the registered trademark for a north american business unit in the other specialty products segment and the registered trademark for a north american business unit in the plumbing products segment ( 2011 only ) were impaired due to changes in the long-term outlook for the business units . the company recognized non-cash , pre-tax impairment charges for other indefinite- lived intangible assets of $ 42 million ( $ 27 million , after tax ) and $ 8 million ( $ 5 million , after tax ) in 2012 and 2011 , respectively . in 2010 , the company recognized non-cash , pre-tax impairment charges for other indefinite-lived intangible assets of $ 10 million ( $ 6 million after tax ) related to the installation and other services segment ( $ 9 million pre-tax ) and the plumbing products segment ( $ 1 million pre-tax ) . .
Conversations:
q0: what was the net change in value of total net goodwill from 2010 to 2011? {answer0}
Question: what was the 2010 value?
Answer:

Answer: 2383.0


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: masco corporation notes to consolidated financial statements ( continued ) h . goodwill and other intangible assets ( continued ) goodwill at december 31 , accumulated impairment losses goodwill at december 31 , 2010 additions ( a ) discontinued operations ( b ) pre-tax impairment charge other ( c ) goodwill at december 31 , cabinets and related products . . . . . . . . . . . $ 587 $ ( 364 ) $ 223 $ 2014 $ 2014 $ ( 44 ) $ 2 $ 181 .

1		gross goodwill at december 31 2010	accumulated impairment losses	net goodwill at december 31 2010	additions ( a )	discontinued operations ( b )	pre-tax impairment charge	other ( c )	net goodwill at december 31 2011

2	cabinets and related products	$ 587	$ -364 ( 364 )	$ 223	$ 2014	$ 2014	$ -44 ( 44 )	$ 2	$ 181

3	plumbing products	536	-340 ( 340 )	196	9	2014	2014	-4 ( 4 )	201

4	installation and other services	1819	-762 ( 762 )	1057	2014	-13 ( 13 )	2014	2014	1044

5	decorative architectural products	294	2014	294	2014	2014	-75 ( 75 )	2014	219

6	other specialty products	980	-367 ( 367 )	613	2014	2014	-367 ( 367 )	2014	246

7	total	$ 4216	$ -1833 ( 1833 )	$ 2383	$ 9	$ -13 ( 13 )	$ -486 ( 486 )	$ -2 ( 2 )	$ 1891

 ( a ) additions include acquisitions . ( b ) during 2011 , the company reclassified the goodwill related to the business units held for sale . subsequent to the reclassification , the company recognized a charge for those business units expected to be divested at a loss ; the charge included a write-down of goodwill of $ 13 million . ( c ) other principally includes the effect of foreign currency translation and purchase price adjustments related to prior-year acquisitions . in the fourth quarters of 2012 and 2011 , the company completed its annual impairment testing of goodwill and other indefinite-lived intangible assets . the impairment test in 2012 indicated there was no impairment of goodwill for any of the company 2019s reporting units . the impairment test in 2011 indicated that goodwill recorded for certain of the company 2019s reporting units was impaired . the company recognized the non-cash , pre-tax impairment charges , in continuing operations , for goodwill of $ 486 million ( $ 330 million , after tax ) for 2011 . in 2011 , the pre-tax impairment charge in the cabinets and related products segment relates to the european ready-to- assemble cabinet manufacturer and reflects the declining demand for certain products , as well as decreased operating margins . the pre-tax impairment charge in the decorative architectural products segment relates to the builders 2019 hardware business and reflects increasing competitive conditions for that business . the pre-tax impairment charge in the other specialty products segment relates to the north american window and door business and reflects the continuing weak level of new home construction activity in the western u.s. , the reduced levels of repair and remodel activity and the expectation that recovery in these segments will be modestly slower than anticipated . the company then assessed the long-lived assets associated with these business units and determined no impairment was necessary at december 31 , 2011 . other indefinite-lived intangible assets were $ 132 million and $ 174 million at december 31 , 2012 and 2011 , respectively , and principally included registered trademarks . in 2012 and 2011 , the impairment test indicated that the registered trademark for a north american business unit in the other specialty products segment and the registered trademark for a north american business unit in the plumbing products segment ( 2011 only ) were impaired due to changes in the long-term outlook for the business units . the company recognized non-cash , pre-tax impairment charges for other indefinite- lived intangible assets of $ 42 million ( $ 27 million , after tax ) and $ 8 million ( $ 5 million , after tax ) in 2012 and 2011 , respectively . in 2010 , the company recognized non-cash , pre-tax impairment charges for other indefinite-lived intangible assets of $ 10 million ( $ 6 million after tax ) related to the installation and other services segment ( $ 9 million pre-tax ) and the plumbing products segment ( $ 1 million pre-tax ) . .
Conversations:
q0: what was the net change in value of total net goodwill from 2010 to 2011? {answer0}
q1: what was the 2010 value? {answer1}
Question: what is the net change divide by the 2010 value?
Answer:

Answer: -0.20646


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: z i m m e r h o l d i n g s , i n c . a n d s u b s i d i a r i e s 2 0 0 3 f o r m 1 0 - k notes to consolidated financial statements ( continued ) the unaudited pro forma results for 2003 include events or changes in circumstances indicate that the carrying $ 90.4 million of expense related to centerpulse hip and knee value of an asset may not be recoverable . an impairment loss litigation , $ 54.4 million of cash income tax benefits as a result would be recognized when estimated future cash flows of centerpulse electing to carry back its 2002 u.s . federal net relating to the asset are less than its carrying amount . operating loss for 5 years versus 10 years , which resulted in depreciation of instruments is recognized as selling , general more losses being carried forward to future years and less and administrative expense , consistent with the classification tax credits going unutilized due to the shorter carry back of instrument cost in periods prior to january 1 , 2003 . period and an $ 8.0 million gain on sale of orquest inc. , an prior to january 1 , 2003 , undeployed instruments were investment previously held by centerpulse . the unaudited carried as a prepaid expense at cost , net of allowances for pro forma results are not necessarily indicative either of the obsolescence ( $ 54.8 million , net , at december 31 , 2002 ) , and results of operations that actually would have resulted had recognized in selling , general and administrative expense in the exchange offers been in effect at the beginning of the the year in which the instruments were placed into service . respective years or of future results . the new method of accounting for instruments was adopted to recognize the cost of these important assets of the transfx company 2019s business within the consolidated balance sheet on june 25 , 2003 , the company acquired the transfx and meaningfully allocate the cost of these assets over the external fixation system product line from immedica , inc . periods benefited , typically five years . for approximately $ 14.8 million cash , which has been the effect of the change during the year ended allocated primarily to goodwill and technology based december 31 , 2003 was to increase earnings before intangible assets . the company has sold the transfx cumulative effect of change in accounting principle by product line since early 2001 under a distribution agreement $ 26.8 million ( $ 17.8 million net of tax ) , or $ 0.08 per diluted with immedica . share . the cumulative effect adjustment of $ 55.1 million ( net of income taxes of $ 34.0 million ) to retroactively apply the implex corp . new capitalization method as if applied in years prior to 2003 on march 2 , 2004 , the company entered into an is included in earnings during the year ended december 31 , amended and restated merger agreement relating to the 2003 . the pro forma amounts shown on the consolidated acquisition of implex corp . ( 2018 2018implex 2019 2019 ) , a privately held statement of earnings have been adjusted for the effect of orthopaedics company based in new jersey , for cash . each the retroactive application on depreciation and related share of implex stock will be converted into the right to income taxes . receive cash having an aggregate value of approximately $ 108.0 million at closing and additional cash earn-out 5 . inventories payments that are contingent on the growth of implex inventories at december 31 , 2003 and 2002 , consist of product sales through 2006 . the net value transferred at the following ( in millions ) : closing will be approximately $ 89 million , which includes .

1		2003	2002

2	finished goods	$ 384.3	$ 206.7

3	raw materials and work in progress	90.8	50.9

4	inventory step-up	52.6	2013

5	inventories net	$ 527.7	$ 257.6

 made by zimmer to implex pursuant to their existing alliance raw materials and work in progress 90.8 50.9 arrangement , escrow and other items . the acquisition will be inventory step-up 52.6 2013 accounted for under the purchase method of accounting . inventories , net $ 527.7 $ 257.6 reserves for obsolete and slow-moving inventory at4 . change in accounting principle december 31 , 2003 and 2002 were $ 47.4 million and instruments are hand held devices used by orthopaedic $ 45.5 million , respectively . provisions charged to expense surgeons during total joint replacement and other surgical were $ 11.6 million , $ 6.0 million and $ 11.9 million for the procedures . effective january 1 , 2003 , instruments are years ended december 31 , 2003 , 2002 and 2001 , respectively . recognized as long-lived assets and are included in property , amounts written off against the reserve were $ 11.7 million , plant and equipment . undeployed instruments are carried at $ 7.1 million and $ 8.5 million for the years ended cost , net of allowances for obsolescence . instruments in the december 31 , 2003 , 2002 and 2001 , respectively . field are carried at cost less accumulated depreciation . following the acquisition of centerpulse , the company depreciation is computed using the straight-line method established a common approach for estimating excess based on average estimated useful lives , determined inventory and instruments . this change in estimate resulted principally in reference to associated product life cycles , in a charge to earnings of $ 3.0 million after tax in the fourth primarily five years . in accordance with sfas no . 144 , the quarter . company reviews instruments for impairment whenever .
Conversations:
Question: what was the total of inventories in 2003?
Answer:

Answer: 527.7


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: z i m m e r h o l d i n g s , i n c . a n d s u b s i d i a r i e s 2 0 0 3 f o r m 1 0 - k notes to consolidated financial statements ( continued ) the unaudited pro forma results for 2003 include events or changes in circumstances indicate that the carrying $ 90.4 million of expense related to centerpulse hip and knee value of an asset may not be recoverable . an impairment loss litigation , $ 54.4 million of cash income tax benefits as a result would be recognized when estimated future cash flows of centerpulse electing to carry back its 2002 u.s . federal net relating to the asset are less than its carrying amount . operating loss for 5 years versus 10 years , which resulted in depreciation of instruments is recognized as selling , general more losses being carried forward to future years and less and administrative expense , consistent with the classification tax credits going unutilized due to the shorter carry back of instrument cost in periods prior to january 1 , 2003 . period and an $ 8.0 million gain on sale of orquest inc. , an prior to january 1 , 2003 , undeployed instruments were investment previously held by centerpulse . the unaudited carried as a prepaid expense at cost , net of allowances for pro forma results are not necessarily indicative either of the obsolescence ( $ 54.8 million , net , at december 31 , 2002 ) , and results of operations that actually would have resulted had recognized in selling , general and administrative expense in the exchange offers been in effect at the beginning of the the year in which the instruments were placed into service . respective years or of future results . the new method of accounting for instruments was adopted to recognize the cost of these important assets of the transfx company 2019s business within the consolidated balance sheet on june 25 , 2003 , the company acquired the transfx and meaningfully allocate the cost of these assets over the external fixation system product line from immedica , inc . periods benefited , typically five years . for approximately $ 14.8 million cash , which has been the effect of the change during the year ended allocated primarily to goodwill and technology based december 31 , 2003 was to increase earnings before intangible assets . the company has sold the transfx cumulative effect of change in accounting principle by product line since early 2001 under a distribution agreement $ 26.8 million ( $ 17.8 million net of tax ) , or $ 0.08 per diluted with immedica . share . the cumulative effect adjustment of $ 55.1 million ( net of income taxes of $ 34.0 million ) to retroactively apply the implex corp . new capitalization method as if applied in years prior to 2003 on march 2 , 2004 , the company entered into an is included in earnings during the year ended december 31 , amended and restated merger agreement relating to the 2003 . the pro forma amounts shown on the consolidated acquisition of implex corp . ( 2018 2018implex 2019 2019 ) , a privately held statement of earnings have been adjusted for the effect of orthopaedics company based in new jersey , for cash . each the retroactive application on depreciation and related share of implex stock will be converted into the right to income taxes . receive cash having an aggregate value of approximately $ 108.0 million at closing and additional cash earn-out 5 . inventories payments that are contingent on the growth of implex inventories at december 31 , 2003 and 2002 , consist of product sales through 2006 . the net value transferred at the following ( in millions ) : closing will be approximately $ 89 million , which includes .

1		2003	2002

2	finished goods	$ 384.3	$ 206.7

3	raw materials and work in progress	90.8	50.9

4	inventory step-up	52.6	2013

5	inventories net	$ 527.7	$ 257.6

 made by zimmer to implex pursuant to their existing alliance raw materials and work in progress 90.8 50.9 arrangement , escrow and other items . the acquisition will be inventory step-up 52.6 2013 accounted for under the purchase method of accounting . inventories , net $ 527.7 $ 257.6 reserves for obsolete and slow-moving inventory at4 . change in accounting principle december 31 , 2003 and 2002 were $ 47.4 million and instruments are hand held devices used by orthopaedic $ 45.5 million , respectively . provisions charged to expense surgeons during total joint replacement and other surgical were $ 11.6 million , $ 6.0 million and $ 11.9 million for the procedures . effective january 1 , 2003 , instruments are years ended december 31 , 2003 , 2002 and 2001 , respectively . recognized as long-lived assets and are included in property , amounts written off against the reserve were $ 11.7 million , plant and equipment . undeployed instruments are carried at $ 7.1 million and $ 8.5 million for the years ended cost , net of allowances for obsolescence . instruments in the december 31 , 2003 , 2002 and 2001 , respectively . field are carried at cost less accumulated depreciation . following the acquisition of centerpulse , the company depreciation is computed using the straight-line method established a common approach for estimating excess based on average estimated useful lives , determined inventory and instruments . this change in estimate resulted principally in reference to associated product life cycles , in a charge to earnings of $ 3.0 million after tax in the fourth primarily five years . in accordance with sfas no . 144 , the quarter . company reviews instruments for impairment whenever .
Conversations:
q0: what was the total of inventories in 2003? {answer0}
Question: and what was it in 2002?
Answer:

Answer: 257.6


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: z i m m e r h o l d i n g s , i n c . a n d s u b s i d i a r i e s 2 0 0 3 f o r m 1 0 - k notes to consolidated financial statements ( continued ) the unaudited pro forma results for 2003 include events or changes in circumstances indicate that the carrying $ 90.4 million of expense related to centerpulse hip and knee value of an asset may not be recoverable . an impairment loss litigation , $ 54.4 million of cash income tax benefits as a result would be recognized when estimated future cash flows of centerpulse electing to carry back its 2002 u.s . federal net relating to the asset are less than its carrying amount . operating loss for 5 years versus 10 years , which resulted in depreciation of instruments is recognized as selling , general more losses being carried forward to future years and less and administrative expense , consistent with the classification tax credits going unutilized due to the shorter carry back of instrument cost in periods prior to january 1 , 2003 . period and an $ 8.0 million gain on sale of orquest inc. , an prior to january 1 , 2003 , undeployed instruments were investment previously held by centerpulse . the unaudited carried as a prepaid expense at cost , net of allowances for pro forma results are not necessarily indicative either of the obsolescence ( $ 54.8 million , net , at december 31 , 2002 ) , and results of operations that actually would have resulted had recognized in selling , general and administrative expense in the exchange offers been in effect at the beginning of the the year in which the instruments were placed into service . respective years or of future results . the new method of accounting for instruments was adopted to recognize the cost of these important assets of the transfx company 2019s business within the consolidated balance sheet on june 25 , 2003 , the company acquired the transfx and meaningfully allocate the cost of these assets over the external fixation system product line from immedica , inc . periods benefited , typically five years . for approximately $ 14.8 million cash , which has been the effect of the change during the year ended allocated primarily to goodwill and technology based december 31 , 2003 was to increase earnings before intangible assets . the company has sold the transfx cumulative effect of change in accounting principle by product line since early 2001 under a distribution agreement $ 26.8 million ( $ 17.8 million net of tax ) , or $ 0.08 per diluted with immedica . share . the cumulative effect adjustment of $ 55.1 million ( net of income taxes of $ 34.0 million ) to retroactively apply the implex corp . new capitalization method as if applied in years prior to 2003 on march 2 , 2004 , the company entered into an is included in earnings during the year ended december 31 , amended and restated merger agreement relating to the 2003 . the pro forma amounts shown on the consolidated acquisition of implex corp . ( 2018 2018implex 2019 2019 ) , a privately held statement of earnings have been adjusted for the effect of orthopaedics company based in new jersey , for cash . each the retroactive application on depreciation and related share of implex stock will be converted into the right to income taxes . receive cash having an aggregate value of approximately $ 108.0 million at closing and additional cash earn-out 5 . inventories payments that are contingent on the growth of implex inventories at december 31 , 2003 and 2002 , consist of product sales through 2006 . the net value transferred at the following ( in millions ) : closing will be approximately $ 89 million , which includes .

1		2003	2002

2	finished goods	$ 384.3	$ 206.7

3	raw materials and work in progress	90.8	50.9

4	inventory step-up	52.6	2013

5	inventories net	$ 527.7	$ 257.6

 made by zimmer to implex pursuant to their existing alliance raw materials and work in progress 90.8 50.9 arrangement , escrow and other items . the acquisition will be inventory step-up 52.6 2013 accounted for under the purchase method of accounting . inventories , net $ 527.7 $ 257.6 reserves for obsolete and slow-moving inventory at4 . change in accounting principle december 31 , 2003 and 2002 were $ 47.4 million and instruments are hand held devices used by orthopaedic $ 45.5 million , respectively . provisions charged to expense surgeons during total joint replacement and other surgical were $ 11.6 million , $ 6.0 million and $ 11.9 million for the procedures . effective january 1 , 2003 , instruments are years ended december 31 , 2003 , 2002 and 2001 , respectively . recognized as long-lived assets and are included in property , amounts written off against the reserve were $ 11.7 million , plant and equipment . undeployed instruments are carried at $ 7.1 million and $ 8.5 million for the years ended cost , net of allowances for obsolescence . instruments in the december 31 , 2003 , 2002 and 2001 , respectively . field are carried at cost less accumulated depreciation . following the acquisition of centerpulse , the company depreciation is computed using the straight-line method established a common approach for estimating excess based on average estimated useful lives , determined inventory and instruments . this change in estimate resulted principally in reference to associated product life cycles , in a charge to earnings of $ 3.0 million after tax in the fourth primarily five years . in accordance with sfas no . 144 , the quarter . company reviews instruments for impairment whenever .
Conversations:
q0: what was the total of inventories in 2003? {answer0}
q1: and what was it in 2002? {answer1}
Question: how much, then, did the 2003 amount represent in relation to this 2002 one?
Answer:

Answer: 2.04852


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: z i m m e r h o l d i n g s , i n c . a n d s u b s i d i a r i e s 2 0 0 3 f o r m 1 0 - k notes to consolidated financial statements ( continued ) the unaudited pro forma results for 2003 include events or changes in circumstances indicate that the carrying $ 90.4 million of expense related to centerpulse hip and knee value of an asset may not be recoverable . an impairment loss litigation , $ 54.4 million of cash income tax benefits as a result would be recognized when estimated future cash flows of centerpulse electing to carry back its 2002 u.s . federal net relating to the asset are less than its carrying amount . operating loss for 5 years versus 10 years , which resulted in depreciation of instruments is recognized as selling , general more losses being carried forward to future years and less and administrative expense , consistent with the classification tax credits going unutilized due to the shorter carry back of instrument cost in periods prior to january 1 , 2003 . period and an $ 8.0 million gain on sale of orquest inc. , an prior to january 1 , 2003 , undeployed instruments were investment previously held by centerpulse . the unaudited carried as a prepaid expense at cost , net of allowances for pro forma results are not necessarily indicative either of the obsolescence ( $ 54.8 million , net , at december 31 , 2002 ) , and results of operations that actually would have resulted had recognized in selling , general and administrative expense in the exchange offers been in effect at the beginning of the the year in which the instruments were placed into service . respective years or of future results . the new method of accounting for instruments was adopted to recognize the cost of these important assets of the transfx company 2019s business within the consolidated balance sheet on june 25 , 2003 , the company acquired the transfx and meaningfully allocate the cost of these assets over the external fixation system product line from immedica , inc . periods benefited , typically five years . for approximately $ 14.8 million cash , which has been the effect of the change during the year ended allocated primarily to goodwill and technology based december 31 , 2003 was to increase earnings before intangible assets . the company has sold the transfx cumulative effect of change in accounting principle by product line since early 2001 under a distribution agreement $ 26.8 million ( $ 17.8 million net of tax ) , or $ 0.08 per diluted with immedica . share . the cumulative effect adjustment of $ 55.1 million ( net of income taxes of $ 34.0 million ) to retroactively apply the implex corp . new capitalization method as if applied in years prior to 2003 on march 2 , 2004 , the company entered into an is included in earnings during the year ended december 31 , amended and restated merger agreement relating to the 2003 . the pro forma amounts shown on the consolidated acquisition of implex corp . ( 2018 2018implex 2019 2019 ) , a privately held statement of earnings have been adjusted for the effect of orthopaedics company based in new jersey , for cash . each the retroactive application on depreciation and related share of implex stock will be converted into the right to income taxes . receive cash having an aggregate value of approximately $ 108.0 million at closing and additional cash earn-out 5 . inventories payments that are contingent on the growth of implex inventories at december 31 , 2003 and 2002 , consist of product sales through 2006 . the net value transferred at the following ( in millions ) : closing will be approximately $ 89 million , which includes .

1		2003	2002

2	finished goods	$ 384.3	$ 206.7

3	raw materials and work in progress	90.8	50.9

4	inventory step-up	52.6	2013

5	inventories net	$ 527.7	$ 257.6

 made by zimmer to implex pursuant to their existing alliance raw materials and work in progress 90.8 50.9 arrangement , escrow and other items . the acquisition will be inventory step-up 52.6 2013 accounted for under the purchase method of accounting . inventories , net $ 527.7 $ 257.6 reserves for obsolete and slow-moving inventory at4 . change in accounting principle december 31 , 2003 and 2002 were $ 47.4 million and instruments are hand held devices used by orthopaedic $ 45.5 million , respectively . provisions charged to expense surgeons during total joint replacement and other surgical were $ 11.6 million , $ 6.0 million and $ 11.9 million for the procedures . effective january 1 , 2003 , instruments are years ended december 31 , 2003 , 2002 and 2001 , respectively . recognized as long-lived assets and are included in property , amounts written off against the reserve were $ 11.7 million , plant and equipment . undeployed instruments are carried at $ 7.1 million and $ 8.5 million for the years ended cost , net of allowances for obsolescence . instruments in the december 31 , 2003 , 2002 and 2001 , respectively . field are carried at cost less accumulated depreciation . following the acquisition of centerpulse , the company depreciation is computed using the straight-line method established a common approach for estimating excess based on average estimated useful lives , determined inventory and instruments . this change in estimate resulted principally in reference to associated product life cycles , in a charge to earnings of $ 3.0 million after tax in the fourth primarily five years . in accordance with sfas no . 144 , the quarter . company reviews instruments for impairment whenever .
Conversations:
q0: what was the total of inventories in 2003? {answer0}
q1: and what was it in 2002? {answer1}
q2: how much, then, did the 2003 amount represent in relation to this 2002 one? {answer2}
Question: and what is that excluding the portion equivalent to the 2002 amount?
Answer:

Answer: 1.04852


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: z i m m e r h o l d i n g s , i n c . a n d s u b s i d i a r i e s 2 0 0 3 f o r m 1 0 - k notes to consolidated financial statements ( continued ) the unaudited pro forma results for 2003 include events or changes in circumstances indicate that the carrying $ 90.4 million of expense related to centerpulse hip and knee value of an asset may not be recoverable . an impairment loss litigation , $ 54.4 million of cash income tax benefits as a result would be recognized when estimated future cash flows of centerpulse electing to carry back its 2002 u.s . federal net relating to the asset are less than its carrying amount . operating loss for 5 years versus 10 years , which resulted in depreciation of instruments is recognized as selling , general more losses being carried forward to future years and less and administrative expense , consistent with the classification tax credits going unutilized due to the shorter carry back of instrument cost in periods prior to january 1 , 2003 . period and an $ 8.0 million gain on sale of orquest inc. , an prior to january 1 , 2003 , undeployed instruments were investment previously held by centerpulse . the unaudited carried as a prepaid expense at cost , net of allowances for pro forma results are not necessarily indicative either of the obsolescence ( $ 54.8 million , net , at december 31 , 2002 ) , and results of operations that actually would have resulted had recognized in selling , general and administrative expense in the exchange offers been in effect at the beginning of the the year in which the instruments were placed into service . respective years or of future results . the new method of accounting for instruments was adopted to recognize the cost of these important assets of the transfx company 2019s business within the consolidated balance sheet on june 25 , 2003 , the company acquired the transfx and meaningfully allocate the cost of these assets over the external fixation system product line from immedica , inc . periods benefited , typically five years . for approximately $ 14.8 million cash , which has been the effect of the change during the year ended allocated primarily to goodwill and technology based december 31 , 2003 was to increase earnings before intangible assets . the company has sold the transfx cumulative effect of change in accounting principle by product line since early 2001 under a distribution agreement $ 26.8 million ( $ 17.8 million net of tax ) , or $ 0.08 per diluted with immedica . share . the cumulative effect adjustment of $ 55.1 million ( net of income taxes of $ 34.0 million ) to retroactively apply the implex corp . new capitalization method as if applied in years prior to 2003 on march 2 , 2004 , the company entered into an is included in earnings during the year ended december 31 , amended and restated merger agreement relating to the 2003 . the pro forma amounts shown on the consolidated acquisition of implex corp . ( 2018 2018implex 2019 2019 ) , a privately held statement of earnings have been adjusted for the effect of orthopaedics company based in new jersey , for cash . each the retroactive application on depreciation and related share of implex stock will be converted into the right to income taxes . receive cash having an aggregate value of approximately $ 108.0 million at closing and additional cash earn-out 5 . inventories payments that are contingent on the growth of implex inventories at december 31 , 2003 and 2002 , consist of product sales through 2006 . the net value transferred at the following ( in millions ) : closing will be approximately $ 89 million , which includes .

1		2003	2002

2	finished goods	$ 384.3	$ 206.7

3	raw materials and work in progress	90.8	50.9

4	inventory step-up	52.6	2013

5	inventories net	$ 527.7	$ 257.6

 made by zimmer to implex pursuant to their existing alliance raw materials and work in progress 90.8 50.9 arrangement , escrow and other items . the acquisition will be inventory step-up 52.6 2013 accounted for under the purchase method of accounting . inventories , net $ 527.7 $ 257.6 reserves for obsolete and slow-moving inventory at4 . change in accounting principle december 31 , 2003 and 2002 were $ 47.4 million and instruments are hand held devices used by orthopaedic $ 45.5 million , respectively . provisions charged to expense surgeons during total joint replacement and other surgical were $ 11.6 million , $ 6.0 million and $ 11.9 million for the procedures . effective january 1 , 2003 , instruments are years ended december 31 , 2003 , 2002 and 2001 , respectively . recognized as long-lived assets and are included in property , amounts written off against the reserve were $ 11.7 million , plant and equipment . undeployed instruments are carried at $ 7.1 million and $ 8.5 million for the years ended cost , net of allowances for obsolescence . instruments in the december 31 , 2003 , 2002 and 2001 , respectively . field are carried at cost less accumulated depreciation . following the acquisition of centerpulse , the company depreciation is computed using the straight-line method established a common approach for estimating excess based on average estimated useful lives , determined inventory and instruments . this change in estimate resulted principally in reference to associated product life cycles , in a charge to earnings of $ 3.0 million after tax in the fourth primarily five years . in accordance with sfas no . 144 , the quarter . company reviews instruments for impairment whenever .
Conversations:
q0: what was the total of inventories in 2003? {answer0}
q1: and what was it in 2002? {answer1}
q2: how much, then, did the 2003 amount represent in relation to this 2002 one? {answer2}
q3: and what is that excluding the portion equivalent to the 2002 amount? {answer3}
Question: between those same two years, what was the change in the total of finished goods, in millions?
Answer:

Answer: 177.6


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: we hold an interest rate swap agreement to hedge the benchmark interest rate of our $ 375 million 5.0% ( 5.0 % ) senior unsecured notes due july 1 , 2014 . the effect of the swap is to convert our 5.0% ( 5.0 % ) fixed interest rate to a variable interest rate based on the three-month libor plus 2.05% ( 2.05 % ) ( 2.42% ( 2.42 % ) as of october 29 , 2011 ) . in addition , we have a term loan facility of $ 145 million that bears interest at a fluctuating rate for each period equal to the libor rate corresponding with the tenor of the interest period plus a spread of 1.25% ( 1.25 % ) ( 1.61% ( 1.61 % ) as of october 29 , 2011 ) . if libor increases by 100 basis points , our annual interest expense would increase by approximately $ 5 million . however , this hypothetical change in interest rates would not impact the interest expense on our $ 375 million of 3% ( 3 % ) fixed-rate debt , which is not hedged . as of october 30 , 2010 , a similar 100 basis point increase in libor would have resulted in an increase of approximately $ 4 million to our annual interest expense . foreign currency exposure as more fully described in note 2i in the notes to consolidated financial statements contained in item 8 of this annual report on form 10-k , we regularly hedge our non-u.s . dollar-based exposures by entering into forward foreign currency exchange contracts . the terms of these contracts are for periods matching the duration of the underlying exposure and generally range from one month to twelve months . currently , our largest foreign currency exposure is the euro , primarily because our european operations have the highest proportion of our local currency denominated expenses . relative to foreign currency exposures existing at october 29 , 2011 and october 30 , 2010 , a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates over the course of the year would expose us to approximately $ 6 million in losses in earnings or cash flows . the market risk associated with our derivative instruments results from currency exchange rates that are expected to offset the market risk of the underlying transactions , assets and liabilities being hedged . the counterparties to the agreements relating to our foreign exchange instruments consist of a number of major international financial institutions with high credit ratings . based on the credit ratings of our counterparties as of october 29 , 2011 , we do not believe that there is significant risk of nonperformance by them . while the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions , they do not represent the amount of our exposure to credit risk . the amounts potentially subject to credit risk ( arising from the possible inability of counterparties to meet the terms of their contracts ) are generally limited to the amounts , if any , by which the counterparties 2019 obligations under the contracts exceed our obligations to the counterparties . the following table illustrates the effect that a 10% ( 10 % ) unfavorable or favorable movement in foreign currency exchange rates , relative to the u.s . dollar , would have on the fair value of our forward exchange contracts as of october 29 , 2011 and october 30 , 2010: .

1		october 29 2011	october 30 2010

2	fair value of forward exchange contracts asset	$ 2472	$ 7256

3	fair value of forward exchange contracts after a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates asset	$ 17859	$ 22062

4	fair value of forward exchange contracts after a 10% ( 10 % ) favorable movement in foreign currency exchange rates liability	$ -13332 ( 13332 )	$ -7396 ( 7396 )

 fair value of forward exchange contracts after a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates asset . . . . . . . . . . . . . . . . . $ 17859 $ 22062 fair value of forward exchange contracts after a 10% ( 10 % ) favorable movement in foreign currency exchange rates liability . . . . . . . . . . . . . . . . . . . . . . . $ ( 13332 ) $ ( 7396 ) the calculation assumes that each exchange rate would change in the same direction relative to the u.s . dollar . in addition to the direct effects of changes in exchange rates , such changes typically affect the volume of sales or the foreign currency sales price as competitors 2019 products become more or less attractive . our sensitivity analysis of the effects of changes in foreign currency exchange rates does not factor in a potential change in sales levels or local currency selling prices. .
Conversations:
Question: what is the net change fair value of forward exchange contracts asset from 2010 to 2011?
Answer:

Answer: -4784.0


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: we hold an interest rate swap agreement to hedge the benchmark interest rate of our $ 375 million 5.0% ( 5.0 % ) senior unsecured notes due july 1 , 2014 . the effect of the swap is to convert our 5.0% ( 5.0 % ) fixed interest rate to a variable interest rate based on the three-month libor plus 2.05% ( 2.05 % ) ( 2.42% ( 2.42 % ) as of october 29 , 2011 ) . in addition , we have a term loan facility of $ 145 million that bears interest at a fluctuating rate for each period equal to the libor rate corresponding with the tenor of the interest period plus a spread of 1.25% ( 1.25 % ) ( 1.61% ( 1.61 % ) as of october 29 , 2011 ) . if libor increases by 100 basis points , our annual interest expense would increase by approximately $ 5 million . however , this hypothetical change in interest rates would not impact the interest expense on our $ 375 million of 3% ( 3 % ) fixed-rate debt , which is not hedged . as of october 30 , 2010 , a similar 100 basis point increase in libor would have resulted in an increase of approximately $ 4 million to our annual interest expense . foreign currency exposure as more fully described in note 2i in the notes to consolidated financial statements contained in item 8 of this annual report on form 10-k , we regularly hedge our non-u.s . dollar-based exposures by entering into forward foreign currency exchange contracts . the terms of these contracts are for periods matching the duration of the underlying exposure and generally range from one month to twelve months . currently , our largest foreign currency exposure is the euro , primarily because our european operations have the highest proportion of our local currency denominated expenses . relative to foreign currency exposures existing at october 29 , 2011 and october 30 , 2010 , a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates over the course of the year would expose us to approximately $ 6 million in losses in earnings or cash flows . the market risk associated with our derivative instruments results from currency exchange rates that are expected to offset the market risk of the underlying transactions , assets and liabilities being hedged . the counterparties to the agreements relating to our foreign exchange instruments consist of a number of major international financial institutions with high credit ratings . based on the credit ratings of our counterparties as of october 29 , 2011 , we do not believe that there is significant risk of nonperformance by them . while the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions , they do not represent the amount of our exposure to credit risk . the amounts potentially subject to credit risk ( arising from the possible inability of counterparties to meet the terms of their contracts ) are generally limited to the amounts , if any , by which the counterparties 2019 obligations under the contracts exceed our obligations to the counterparties . the following table illustrates the effect that a 10% ( 10 % ) unfavorable or favorable movement in foreign currency exchange rates , relative to the u.s . dollar , would have on the fair value of our forward exchange contracts as of october 29 , 2011 and october 30 , 2010: .

1		october 29 2011	october 30 2010

2	fair value of forward exchange contracts asset	$ 2472	$ 7256

3	fair value of forward exchange contracts after a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates asset	$ 17859	$ 22062

4	fair value of forward exchange contracts after a 10% ( 10 % ) favorable movement in foreign currency exchange rates liability	$ -13332 ( 13332 )	$ -7396 ( 7396 )

 fair value of forward exchange contracts after a 10% ( 10 % ) unfavorable movement in foreign currency exchange rates asset . . . . . . . . . . . . . . . . . $ 17859 $ 22062 fair value of forward exchange contracts after a 10% ( 10 % ) favorable movement in foreign currency exchange rates liability . . . . . . . . . . . . . . . . . . . . . . . $ ( 13332 ) $ ( 7396 ) the calculation assumes that each exchange rate would change in the same direction relative to the u.s . dollar . in addition to the direct effects of changes in exchange rates , such changes typically affect the volume of sales or the foreign currency sales price as competitors 2019 products become more or less attractive . our sensitivity analysis of the effects of changes in foreign currency exchange rates does not factor in a potential change in sales levels or local currency selling prices. .
Conversations:
q0: what is the net change fair value of forward exchange contracts asset from 2010 to 2011? {answer0}
Question: what percentage change does this represent?
Answer:

Answer: -0.65932


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: management 2019s discussion and analysis of financial condition and results of operations 2013 ( continued ) ( amounts in millions , except per share amounts ) liquidity and capital resources cash flow overview the following tables summarize key financial data relating to our liquidity , capital resources and uses of capital. .

1	cash flow data	years ended december 31 , 2015	years ended december 31 , 2014	years ended december 31 , 2013

2	net income adjusted to reconcile net income to net cashprovided by operating activities1	$ 848.2	$ 831.2	$ 598.4

3	net cash used in working capital2	-117.5 ( 117.5 )	-131.1 ( 131.1 )	-9.6 ( 9.6 )

4	changes in other non-current assets and liabilities using cash	-56.7 ( 56.7 )	-30.6 ( 30.6 )	4.1

5	net cash provided by operating activities	$ 674.0	$ 669.5	$ 592.9

6	net cash used in investing activities	-202.8 ( 202.8 )	-200.8 ( 200.8 )	-224.5 ( 224.5 )

7	net cash used in financing activities	-472.8 ( 472.8 )	-343.9 ( 343.9 )	-1212.3 ( 1212.3 )

 1 reflects net income adjusted primarily for depreciation and amortization of fixed assets and intangible assets , amortization of restricted stock and other non-cash compensation , non-cash ( gain ) loss related to early extinguishment of debt , losses on sales of businesses and deferred income taxes . 2 reflects changes in accounts receivable , expenditures billable to clients , other current assets , accounts payable and accrued liabilities . operating activities net cash provided by operating activities during 2015 was $ 674.0 , which was an improvement of $ 4.5 as compared to 2014 , primarily as a result of an improvement in working capital usage of $ 13.6 . due to the seasonality of our business , we typically generate cash from working capital in the second half of a year and use cash from working capital in the first half of a year , with the largest impacts in the first and fourth quarters . our net working capital usage in 2015 was primarily attributable to our media businesses . net cash provided by operating activities during 2014 was $ 669.5 , which was an improvement of $ 76.6 as compared to 2013 , primarily as a result of an increase in net income , offset by an increase in working capital usage of $ 121.5 . our net working capital usage in 2014 was impacted by our media businesses . the timing of media buying on behalf of our clients affects our working capital and operating cash flow . in most of our businesses , our agencies enter into commitments to pay production and media costs on behalf of clients . to the extent possible , we pay production and media charges after we have received funds from our clients . the amounts involved substantially exceed our revenues and primarily affect the level of accounts receivable , expenditures billable to clients , accounts payable and accrued liabilities . our assets include both cash received and accounts receivable from clients for these pass-through arrangements , while our liabilities include amounts owed on behalf of clients to media and production suppliers . our accrued liabilities are also affected by the timing of certain other payments . for example , while annual cash incentive awards are accrued throughout the year , they are generally paid during the first quarter of the subsequent year . investing activities net cash used in investing activities during 2015 primarily related to payments for capital expenditures of $ 161.1 , largely attributable to purchases of leasehold improvements and computer hardware . net cash used in investing activities during 2014 primarily related to payments for capital expenditures and acquisitions . capital expenditures of $ 148.7 related primarily to computer hardware and software and leasehold improvements . we made payments of $ 67.8 related to acquisitions completed during 2014 , net of cash acquired. .
Conversations:
Question: what was the change in the total cash flow between 2014 and 2015?
Answer:

Answer: 17.0


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: management 2019s discussion and analysis of financial condition and results of operations 2013 ( continued ) ( amounts in millions , except per share amounts ) liquidity and capital resources cash flow overview the following tables summarize key financial data relating to our liquidity , capital resources and uses of capital. .

1	cash flow data	years ended december 31 , 2015	years ended december 31 , 2014	years ended december 31 , 2013

2	net income adjusted to reconcile net income to net cashprovided by operating activities1	$ 848.2	$ 831.2	$ 598.4

3	net cash used in working capital2	-117.5 ( 117.5 )	-131.1 ( 131.1 )	-9.6 ( 9.6 )

4	changes in other non-current assets and liabilities using cash	-56.7 ( 56.7 )	-30.6 ( 30.6 )	4.1

5	net cash provided by operating activities	$ 674.0	$ 669.5	$ 592.9

6	net cash used in investing activities	-202.8 ( 202.8 )	-200.8 ( 200.8 )	-224.5 ( 224.5 )

7	net cash used in financing activities	-472.8 ( 472.8 )	-343.9 ( 343.9 )	-1212.3 ( 1212.3 )

 1 reflects net income adjusted primarily for depreciation and amortization of fixed assets and intangible assets , amortization of restricted stock and other non-cash compensation , non-cash ( gain ) loss related to early extinguishment of debt , losses on sales of businesses and deferred income taxes . 2 reflects changes in accounts receivable , expenditures billable to clients , other current assets , accounts payable and accrued liabilities . operating activities net cash provided by operating activities during 2015 was $ 674.0 , which was an improvement of $ 4.5 as compared to 2014 , primarily as a result of an improvement in working capital usage of $ 13.6 . due to the seasonality of our business , we typically generate cash from working capital in the second half of a year and use cash from working capital in the first half of a year , with the largest impacts in the first and fourth quarters . our net working capital usage in 2015 was primarily attributable to our media businesses . net cash provided by operating activities during 2014 was $ 669.5 , which was an improvement of $ 76.6 as compared to 2013 , primarily as a result of an increase in net income , offset by an increase in working capital usage of $ 121.5 . our net working capital usage in 2014 was impacted by our media businesses . the timing of media buying on behalf of our clients affects our working capital and operating cash flow . in most of our businesses , our agencies enter into commitments to pay production and media costs on behalf of clients . to the extent possible , we pay production and media charges after we have received funds from our clients . the amounts involved substantially exceed our revenues and primarily affect the level of accounts receivable , expenditures billable to clients , accounts payable and accrued liabilities . our assets include both cash received and accounts receivable from clients for these pass-through arrangements , while our liabilities include amounts owed on behalf of clients to media and production suppliers . our accrued liabilities are also affected by the timing of certain other payments . for example , while annual cash incentive awards are accrued throughout the year , they are generally paid during the first quarter of the subsequent year . investing activities net cash used in investing activities during 2015 primarily related to payments for capital expenditures of $ 161.1 , largely attributable to purchases of leasehold improvements and computer hardware . net cash used in investing activities during 2014 primarily related to payments for capital expenditures and acquisitions . capital expenditures of $ 148.7 related primarily to computer hardware and software and leasehold improvements . we made payments of $ 67.8 related to acquisitions completed during 2014 , net of cash acquired. .
Conversations:
q0: what was the change in the total cash flow between 2014 and 2015? {answer0}
Question: so what was the percentage increase during this time?
Answer:

Answer: 0.02045


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: management 2019s discussion and analysis of financial condition and results of operations 2013 ( continued ) ( amounts in millions , except per share amounts ) liquidity and capital resources cash flow overview the following tables summarize key financial data relating to our liquidity , capital resources and uses of capital. .

1	cash flow data	years ended december 31 , 2015	years ended december 31 , 2014	years ended december 31 , 2013

2	net income adjusted to reconcile net income to net cashprovided by operating activities1	$ 848.2	$ 831.2	$ 598.4

3	net cash used in working capital2	-117.5 ( 117.5 )	-131.1 ( 131.1 )	-9.6 ( 9.6 )

4	changes in other non-current assets and liabilities using cash	-56.7 ( 56.7 )	-30.6 ( 30.6 )	4.1

5	net cash provided by operating activities	$ 674.0	$ 669.5	$ 592.9

6	net cash used in investing activities	-202.8 ( 202.8 )	-200.8 ( 200.8 )	-224.5 ( 224.5 )

7	net cash used in financing activities	-472.8 ( 472.8 )	-343.9 ( 343.9 )	-1212.3 ( 1212.3 )

 1 reflects net income adjusted primarily for depreciation and amortization of fixed assets and intangible assets , amortization of restricted stock and other non-cash compensation , non-cash ( gain ) loss related to early extinguishment of debt , losses on sales of businesses and deferred income taxes . 2 reflects changes in accounts receivable , expenditures billable to clients , other current assets , accounts payable and accrued liabilities . operating activities net cash provided by operating activities during 2015 was $ 674.0 , which was an improvement of $ 4.5 as compared to 2014 , primarily as a result of an improvement in working capital usage of $ 13.6 . due to the seasonality of our business , we typically generate cash from working capital in the second half of a year and use cash from working capital in the first half of a year , with the largest impacts in the first and fourth quarters . our net working capital usage in 2015 was primarily attributable to our media businesses . net cash provided by operating activities during 2014 was $ 669.5 , which was an improvement of $ 76.6 as compared to 2013 , primarily as a result of an increase in net income , offset by an increase in working capital usage of $ 121.5 . our net working capital usage in 2014 was impacted by our media businesses . the timing of media buying on behalf of our clients affects our working capital and operating cash flow . in most of our businesses , our agencies enter into commitments to pay production and media costs on behalf of clients . to the extent possible , we pay production and media charges after we have received funds from our clients . the amounts involved substantially exceed our revenues and primarily affect the level of accounts receivable , expenditures billable to clients , accounts payable and accrued liabilities . our assets include both cash received and accounts receivable from clients for these pass-through arrangements , while our liabilities include amounts owed on behalf of clients to media and production suppliers . our accrued liabilities are also affected by the timing of certain other payments . for example , while annual cash incentive awards are accrued throughout the year , they are generally paid during the first quarter of the subsequent year . investing activities net cash used in investing activities during 2015 primarily related to payments for capital expenditures of $ 161.1 , largely attributable to purchases of leasehold improvements and computer hardware . net cash used in investing activities during 2014 primarily related to payments for capital expenditures and acquisitions . capital expenditures of $ 148.7 related primarily to computer hardware and software and leasehold improvements . we made payments of $ 67.8 related to acquisitions completed during 2014 , net of cash acquired. .
Conversations:
q0: what was the change in the total cash flow between 2014 and 2015? {answer0}
q1: so what was the percentage increase during this time? {answer1}
Question: and converted from a decimal to a percentage?
Answer:

Answer: 2.04524


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: management 2019s discussion and analysis of financial condition and results of operations 2013 ( continued ) ( amounts in millions , except per share amounts ) liquidity and capital resources cash flow overview the following tables summarize key financial data relating to our liquidity , capital resources and uses of capital. .

1	cash flow data	years ended december 31 , 2015	years ended december 31 , 2014	years ended december 31 , 2013

2	net income adjusted to reconcile net income to net cashprovided by operating activities1	$ 848.2	$ 831.2	$ 598.4

3	net cash used in working capital2	-117.5 ( 117.5 )	-131.1 ( 131.1 )	-9.6 ( 9.6 )

4	changes in other non-current assets and liabilities using cash	-56.7 ( 56.7 )	-30.6 ( 30.6 )	4.1

5	net cash provided by operating activities	$ 674.0	$ 669.5	$ 592.9

6	net cash used in investing activities	-202.8 ( 202.8 )	-200.8 ( 200.8 )	-224.5 ( 224.5 )

7	net cash used in financing activities	-472.8 ( 472.8 )	-343.9 ( 343.9 )	-1212.3 ( 1212.3 )

 1 reflects net income adjusted primarily for depreciation and amortization of fixed assets and intangible assets , amortization of restricted stock and other non-cash compensation , non-cash ( gain ) loss related to early extinguishment of debt , losses on sales of businesses and deferred income taxes . 2 reflects changes in accounts receivable , expenditures billable to clients , other current assets , accounts payable and accrued liabilities . operating activities net cash provided by operating activities during 2015 was $ 674.0 , which was an improvement of $ 4.5 as compared to 2014 , primarily as a result of an improvement in working capital usage of $ 13.6 . due to the seasonality of our business , we typically generate cash from working capital in the second half of a year and use cash from working capital in the first half of a year , with the largest impacts in the first and fourth quarters . our net working capital usage in 2015 was primarily attributable to our media businesses . net cash provided by operating activities during 2014 was $ 669.5 , which was an improvement of $ 76.6 as compared to 2013 , primarily as a result of an increase in net income , offset by an increase in working capital usage of $ 121.5 . our net working capital usage in 2014 was impacted by our media businesses . the timing of media buying on behalf of our clients affects our working capital and operating cash flow . in most of our businesses , our agencies enter into commitments to pay production and media costs on behalf of clients . to the extent possible , we pay production and media charges after we have received funds from our clients . the amounts involved substantially exceed our revenues and primarily affect the level of accounts receivable , expenditures billable to clients , accounts payable and accrued liabilities . our assets include both cash received and accounts receivable from clients for these pass-through arrangements , while our liabilities include amounts owed on behalf of clients to media and production suppliers . our accrued liabilities are also affected by the timing of certain other payments . for example , while annual cash incentive awards are accrued throughout the year , they are generally paid during the first quarter of the subsequent year . investing activities net cash used in investing activities during 2015 primarily related to payments for capital expenditures of $ 161.1 , largely attributable to purchases of leasehold improvements and computer hardware . net cash used in investing activities during 2014 primarily related to payments for capital expenditures and acquisitions . capital expenditures of $ 148.7 related primarily to computer hardware and software and leasehold improvements . we made payments of $ 67.8 related to acquisitions completed during 2014 , net of cash acquired. .
Conversations:
q0: what was the change in the total cash flow between 2014 and 2015? {answer0}
q1: so what was the percentage increase during this time? {answer1}
q2: and converted from a decimal to a percentage? {answer2}
Question: what was the net change in cash from operating and investing activities?
Answer:

Answer: 471.2


Question:
In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:
Context: management 2019s discussion and analysis of financial condition and results of operations 2013 ( continued ) ( amounts in millions , except per share amounts ) liquidity and capital resources cash flow overview the following tables summarize key financial data relating to our liquidity , capital resources and uses of capital. .

1	cash flow data	years ended december 31 , 2015	years ended december 31 , 2014	years ended december 31 , 2013

2	net income adjusted to reconcile net income to net cashprovided by operating activities1	$ 848.2	$ 831.2	$ 598.4

3	net cash used in working capital2	-117.5 ( 117.5 )	-131.1 ( 131.1 )	-9.6 ( 9.6 )

4	changes in other non-current assets and liabilities using cash	-56.7 ( 56.7 )	-30.6 ( 30.6 )	4.1

5	net cash provided by operating activities	$ 674.0	$ 669.5	$ 592.9

6	net cash used in investing activities	-202.8 ( 202.8 )	-200.8 ( 200.8 )	-224.5 ( 224.5 )

7	net cash used in financing activities	-472.8 ( 472.8 )	-343.9 ( 343.9 )	-1212.3 ( 1212.3 )

 1 reflects net income adjusted primarily for depreciation and amortization of fixed assets and intangible assets , amortization of restricted stock and other non-cash compensation , non-cash ( gain ) loss related to early extinguishment of debt , losses on sales of businesses and deferred income taxes . 2 reflects changes in accounts receivable , expenditures billable to clients , other current assets , accounts payable and accrued liabilities . operating activities net cash provided by operating activities during 2015 was $ 674.0 , which was an improvement of $ 4.5 as compared to 2014 , primarily as a result of an improvement in working capital usage of $ 13.6 . due to the seasonality of our business , we typically generate cash from working capital in the second half of a year and use cash from working capital in the first half of a year , with the largest impacts in the first and fourth quarters . our net working capital usage in 2015 was primarily attributable to our media businesses . net cash provided by operating activities during 2014 was $ 669.5 , which was an improvement of $ 76.6 as compared to 2013 , primarily as a result of an increase in net income , offset by an increase in working capital usage of $ 121.5 . our net working capital usage in 2014 was impacted by our media businesses . the timing of media buying on behalf of our clients affects our working capital and operating cash flow . in most of our businesses , our agencies enter into commitments to pay production and media costs on behalf of clients . to the extent possible , we pay production and media charges after we have received funds from our clients . the amounts involved substantially exceed our revenues and primarily affect the level of accounts receivable , expenditures billable to clients , accounts payable and accrued liabilities . our assets include both cash received and accounts receivable from clients for these pass-through arrangements , while our liabilities include amounts owed on behalf of clients to media and production suppliers . our accrued liabilities are also affected by the timing of certain other payments . for example , while annual cash incentive awards are accrued throughout the year , they are generally paid during the first quarter of the subsequent year . investing activities net cash used in investing activities during 2015 primarily related to payments for capital expenditures of $ 161.1 , largely attributable to purchases of leasehold improvements and computer hardware . net cash used in investing activities during 2014 primarily related to payments for capital expenditures and acquisitions . capital expenditures of $ 148.7 related primarily to computer hardware and software and leasehold improvements . we made payments of $ 67.8 related to acquisitions completed during 2014 , net of cash acquired. .
Conversations:
q0: what was the change in the total cash flow between 2014 and 2015? {answer0}
q1: so what was the percentage increase during this time? {answer1}
q2: and converted from a decimal to a percentage? {answer2}
q3: what was the net change in cash from operating and investing activities? {answer3}
Question: and the total net change in cash for 2015?
Answer:

Answer: -1.6